stockrow
Friday 6 November 2026
Export HCTI’s income statement to Excel — free account
Healthcare Triangle, Inc.
HCTI Healthcare Health Information Services
Healthcare Triangle, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.9 million, up 18.8% from fiscal 2024.
- Revenue
- +158.4%
- EPS
- +95.5%
- Free cash flow
- +67.5%
- Total debt
- +2,749.9%
Quarter to June 2026, against a year earlier
3.66
0.07
+1.95%
Follow HCTI
Alert me
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 3 | 4 | 3 | 4 | — |
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
Altman Z-Score |
— | — | — | 562,517.65 | 7,029.15 | 12,460.73 | (20.63) | (3.33) |
P/S ratio |
— | 9,239,979.33 | 9,239,979.33 | 225,357.60 | 2,245.39 | 5,362.16 | 0.00 | 0.17 |
Altman Z″-Score (non-manufacturers) |
— | 1.34 | 3.08 | 1.66 | (3.29) | (23.23) | (91.66) | (8.14) |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | — | (1.04) | (1.44) | (4.17) | (8.50) | (15.50) | 0.56 |
P/Operating CF |
— | (788,264,522.27) | (788,264,522.27) | (2,457,749.67) | (46,244.23) | 297,228.20 | 0.00 | (0.34) |
P/B ratio |
— | 114,114,666.05 | 114,114,666.05 | 492,616.20 | 8,317.09 | 0.00 | 0.00 | 0.94 |
Price to Tangible BV |
— | 436,625,254.67 | 436,625,254.67 | 1,811,386.15 | 194,767.74 | 0.00 | 0.00 | 0.00 |
EV/Sales |
— | 9,239,979.35 | 9,239,979.35 | 225,357.61 | 2,245.42 | 5,362.24 | 0.30 | 0.46 |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | (118,340,811.74) | (118,340,811.74) | (1,117,598.83) | (39,628.16) | (82,771.89) | (3.25) | (0.38) |
EV/FCF |
— | (116,117,279.90) | (116,117,279.90) | (1,102,469.33) | (11,487.70) | (32,716.34) | (1.48) | (0.35) |
Quick Ratio |
— | 0.83 | 1.15 | 1.83 | 1.13 | 0.59 | 0.16 | 0.76 |
Current Ratio |
— | 0.85 | 1.18 | 1.89 | 1.26 | 0.69 | 0.21 | 1.03 |
Net Debt/EBITDA |
— | (0.40) | (0.33) | (0.11) | (0.15) | (0.43) | (0.91) | (0.35) |
Debt/Assets |
0.00% | 0.00% | 6.79% | 8.97% | 11.62% | 56.65% | 135.14% | 47.22% |
Debt/Equity |
— | 0.00 | 0.17 | 0.14 | 0.19 | (2.79) | (0.52) | 1.08 |
Asset Turnover |
— | 6.96 | 3.24 | 1.97 | 2.02 | 2.40 | 2.65 | 1.12 |
Operating CF/Net income |
— | 3.39 | (0.31) | 1.20 | 0.18 | 0.25 | 0.18 | 1.74 |
Capex/Depreciation |
— | (4.70) | (0.59) | (2.20) | (0.98) | (0.01) | 0.00 | (1.62) |
Interest Coverage |
— | 31.73 | 14.97 | (9.45) | (49.13) | (7.95) | (3.92) | (17.26) |
| — | 37.19% | 74.67% | (58.14%) | (100.68%) | (157.97%) | 85.64% | 188.76% | |
| — | 28.41% | 24.31% | (33.31%) | (63.28%) | (62.89%) | (135.37%) | (76.74%) | |
ROIC |
— | 104.31% | 19.98% | (20.20%) | (48.37%) | (381.70%) | 0.00% | (46.86%) |
Return on Tangible Assets |
— | (135.47%) | 186.14% | (105.72%) | (854.13%) | 353.81% | 106.38% | (2,603.30%) |
Average Days of Receivables |
— | 52.97 | 74.50 | 100.09 | 44.48 | 39.52 | 34.64 | 54.39 |
Research and Development Expense of Revenue |
— | 3.53% | 5.56% | 14.91% | 12.98% | 2.41% | 3.67% | 3.86% |
Selling, General and Administrative Expense of Revenue |
— | 8.32% | 15.52% | 26.09% | 26.99% | 31.31% | 52.61% | 75.02% |
Intangible Assets out of Total Assets |
0.00 | 0.35 | 0.24 | 0.48 | 0.57 | 0.13 | 0.00 | 0.25 |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 0.15% | 0.56% | 0.50% | 0.74% | 3.25% |
Graham Net Nets |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | 3.95 | 0.00 | 28,927.20 |
Earnings Yield |
— | 0.00% | 0.00% | 0.00% | (69.12%) | 0.00% | (3.73%) | 6,055.29% |
Free Cash Flow Yield |
— | 0.00% | 0.00% | 0.00% | (0.01%) | 0.00% | 0.00% | (766.52%) |
Revenue per Share |
— | 8.17 | 1.12 | 1.20 | 12.54 | 7.95 | 0.00 | 4,480.97 |
Operating CF per Share |
— | 1.13 | (0.03) | (0.24) | (0.71) | (0.51) | 0.00 | (5,330.00) |
Capex per Share |
— | (1.04) | (0.02) | (0.11) | (0.91) | 0.00 | 0.00 | (485.16) |
Free Cash Flow per Share |
— | 0.09 | (0.04) | (0.35) | (1.62) | (0.52) | 0.00 | (5,815.16) |
Cash per Share |
— | 0.28 | 0.05 | 0.06 | 0.37 | 0.30 | 0.00 | 2,459.68 |
Shareholders Equity per Share |
— | 0.56 | 0.16 | 0.55 | 3.39 | (0.33) | 0.00 | 3,207.74 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.56 | 0.16 | 0.55 | 3.39 | (0.33) | 0.00 | 3,207.74 |
Free Cash Flow |
— | 0.32 | (1.21) | (10.24) | (5.92) | (2.16) | (1.08) | (18.03) |
Working Capital |
— | (0.91) | 1.25 | 5.55 | 1.60 | (2.50) | (5.62) | 0.36 |
Capital Expenditures |
— | (3.65) | (0.48) | (3.13) | (3.32) | (0.01) | — | (1.50) |
Net Current Asset Value |
— | (0.99) | 1.25 | 3.33 | (0.63) | (2.60) | (5.62) | 0.36 |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | 0.13 | 0.02 | 0.09 | 0.07 | 0.00 | 0.00 | 0.11 |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
— | 18.66 | 50.84 | 19.22 | 42.18 | 35.59 | 155.67 | 185.60 |
Cash ROIC |
— | 10.81% | (18.69%) | (50.91%) | (36.67%) | (58.02%) | 44.23% | (63.69%) |
Accounts Receivable Turnover |
— | 5.44 | 5.93 | 4.39 | 6.01 | 7.23 | 4.97 | 8.74 |
Accounts Payable Turnover |
— | 4.84 | 4.82 | 7.95 | 20.63 | 15.39 | 3.92 | 7.31 |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
— | 81.33 | 69.78 | 27.62 | 15.63 | 26.98 | 105.24 | 22.63 |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | 5.28 | 5.28 | 8.03 | 7.63 | 4.59 | 2.35 | 1.59 |
Average Payables |
— | 4.72 | 4.72 | 3.11 | 1.68 | 1.72 | 2.25 | 1.64 |
Average Assets |
— | 4.13 | 9.68 | 17.86 | 22.69 | 13.81 | 4.41 | 12.35 |
Average Common Equity |
— | 3.15 | 3.15 | 10.23 | 14.26 | 5.50 | (6.97) | (5.02) |
Columns are period end dates · fundamentals updated 2 Nov 2026